Key Financial Data Of Group

Chordia Therapeutics,Inc - Filing #7339264

Concept	As at 2024-03-31	As at 2023-08-31	2022-09-01 to 2023-08-31	As at 2022-08-31	2021-09-01 to 2022-08-31	2020-09-01 to 2021-08-31	As at 2021-08-31	2019-09-01 to 2020-08-31	As at 2020-08-31	2018-09-01 to 2019-08-31	As at 2019-08-31
Key financial data of group
Business results of group
Ordinary profit (loss)	—	—	225,761,000 JPY	—	-1,776,640,000 JPY	-525,207,000 JPY	—	-974,949,000 JPY	—	-645,901,000 JPY	—
Net assets	—	4,500,881,000 JPY	—	4,277,539,000 JPY	—	—	2,056,435,000 JPY	—	1,023,087,000 JPY	—	1,999,936,000 JPY
Total assets	—	4,909,123,000 JPY	—	4,498,947,000 JPY	—	—	2,271,382,000 JPY	—	1,172,898,000 JPY	—	2,155,061,000 JPY
Net assets per share	—	79.28	—	-72.35	—	—	-11,638.77	—	-12,562.38	—	-5,677.64
Basic earnings (loss) per share	—	—	3.96	—	-39.78	-3,016.58	—	-6,884.75	—	-4,927.57	—
Diluted earnings per share	—	—		—			—		—		—
Equity-to-asset ratio	—	0.912 xbrli:pure	—	0.945 xbrli:pure	—	—	0.894 xbrli:pure	—	0.872 xbrli:pure	—	0.928 xbrli:pure
Rate of return on equity	—	—	0.051 xbrli:pure	—	xbrli:pure	xbrli:pure	—	xbrli:pure	—	xbrli:pure	—
Price-earnings ratio	—	—	xbrli:pure	—	xbrli:pure	xbrli:pure	—	xbrli:pure	—	xbrli:pure	—
Net cash provided by (used in) operating activities	—	—	543,731,000 JPY	—	-1,704,131,000 JPY	JPY	—	JPY	—	JPY	—
Net cash provided by (used in) investing activities	—	—	345,000 JPY	—	-14,696,000 JPY	JPY	—	JPY	—	JPY	—
Net cash provided by (used in) financing activities	—	—	JPY	—	3,975,637,000 JPY	JPY	—	JPY	—	JPY	—
Cash and cash equivalents	—	4,799,035,000 JPY	—	4,254,958,000 JPY	—	—	JPY	—	JPY	—	JPY
Number of employees	21 xbrli:pure	21 xbrli:pure	—	17 xbrli:pure	—	—	15 xbrli:pure	—	16 xbrli:pure	—	12 xbrli:pure
Average number of temporary employees	2 xbrli:pure	3 xbrli:pure	—	3 xbrli:pure	—	—	1 xbrli:pure	—	xbrli:pure	—	xbrli:pure